InsiderTrades.com logo
How Low-Cost Stocks Generate Monthly Income
From Darwin   |   Ad
Are you ready to transform your investment strategy and generate a steady monthly income? We’re excited to offer you our exclusive report, "Options Trading Strategy: 2 (Surprisingly) Low-Cost Stocks Primed for Generating Monthly Income," FREE!
👉 Yes, I Want the Free Report! 👈

CRBP Insider Trading

Insider Ownership Percentage: 4.00%
Insider Buying (Last 12 Months): $40,378,055.68
Insider Selling (Last 12 Months): $2,530,798.76

Corbus Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Corbus Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Corbus Pharmaceuticals Share Price & Price History

Current Price: $12.75
Price Change: ▼ Price Decrease of -0.39 (-2.97%)
As of 12/27/2024 06:45 PM ET

This chart shows the closing price history over time for CRBP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Has Trump Finally Gone Too Far?
From Insiders Exposed   |   Ad
Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.
Register For The Webinar To Discover

Corbus Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/20/2024Cormorant Asset Management, LpMajor ShareholderBuy350,000$20.01$7,003,500.002,375,000View SEC Filing Icon  
6/18/2024Sean F MoranCFOSell1,958$42.12$82,470.9648,605View SEC Filing Icon  
6/17/2024Yuval CohenCEOSell11,103$46.02$510,960.0684,400View SEC Filing Icon  
6/14/2024Sean F MoranCFOSell9,355$49.87$466,533.8548,605View SEC Filing Icon  
6/14/2024Yuval CohenCEOSell29,317$50.17$1,470,833.8984,400View SEC Filing Icon  
3/7/2024Cormorant Asset Management, LpMajor ShareholderBuy250,000$40.05$10,012,500.001,725,000View SEC Filing Icon  
2/2/2024Cormorant Asset Management, LpMajor ShareholderBuy750,000$19.00$14,250,000.001,475,000View SEC Filing Icon  
1/26/2024Cormorant Asset Management, LpMajor ShareholderBuy282,632$32.24$9,112,055.68725,000View SEC Filing Icon  
8/10/2022Craig Stuart MillianCOOBuy5,000$0.25$1,250.0027,000View SEC Filing Icon  
8/10/2022Sean F MoranCFOBuy20,000$0.26$5,200.00199,272View SEC Filing Icon  
8/10/2022Yuval CohenCEOBuy3,800$0.26$988.0098,230View SEC Filing Icon  
5/16/2022Sean F MoranCFOBuy12,000$0.30$3,600.00179,272View SEC Filing Icon  
5/16/2022Yuval CohenCEOBuy10,500$0.25$2,625.0094,430View SEC Filing Icon  
3/10/2022Craig Stuart MillianCOOBuy10,000$0.37$3,700.00View SEC Filing Icon  
3/10/2022Sean F MoranCFOBuy15,000$0.37$5,550.00View SEC Filing Icon  
3/9/2022Yuval CohenCEOBuy8,600$0.37$3,182.00View SEC Filing Icon  
See Full Table
BITCOIN
From Awesomely, LLC   |   Ad
Did you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this...
Watch this short video

SEC Filings (Institutional Ownership Changes) for Corbus Pharmaceuticals (NASDAQ:CRBP)

64.64% of Corbus Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CRBP by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Corbus Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
12/26/2024JPMorgan Chase & Co.5,507$0.11M0.0%+27.0%0.045%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC249,759$5.15M0.0%+8.1%2.051%Search for SEC Filing on Google Icon
11/15/2024Vestcor Inc3,100$64K0.0%N/A0.025%Search for SEC Filing on Google Icon
11/15/2024Y Intercept Hong Kong Ltd18,372$0.38M0.0%N/A0.151%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP23,801$0.49M0.0%N/A0.195%Search for SEC Filing on Google Icon
11/15/2024Wexford Capital LP68,556$1.41M0.3%+55.3%0.563%Search for SEC Filing on Google Icon
11/15/2024State Street Corp595,576$12.29M0.0%+34.6%4.890%Search for SEC Filing on Google Icon
11/15/2024HighVista Strategies LLC75,292$1.55M0.5%+94.1%0.618%Search for SEC Filing on Google Icon
11/14/2024Walleye Capital LLC36,963$0.76M0.0%-75.4%0.303%Search for SEC Filing on Google Icon
11/14/2024Acuta Capital Partners LLC18,500$0.38M0.3%-71.3%0.152%Search for SEC Filing on Google Icon
11/14/2024MetLife Investment Management LLC5,951$0.12M0.0%N/A0.049%Search for SEC Filing on Google Icon
11/13/2024FMR LLC10,028$0.21M0.0%+33.0%0.082%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company22,731$0.47M0.0%+7.6%0.187%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.93,643$1.93M0.0%+224.7%0.778%Search for SEC Filing on Google Icon
11/12/2024HealthInvest Partners AB69,573$1.44M0.7%+77.9%0.578%Search for SEC Filing on Google Icon
11/5/2024Victory Capital Management Inc.24,760$0.51M0.0%+29.9%0.206%Search for SEC Filing on Google Icon
10/25/2024abrdn plc26,894$0.56M0.0%+422.9%0.252%Search for SEC Filing on Google Icon
10/23/2024Assenagon Asset Management S.A.221,184$4.56M0.0%-7.4%2.070%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC7,331$0.15M0.0%N/A0.069%Search for SEC Filing on Google Icon
8/19/2024Point72 Asset Management L.P.216,515$9.80M0.0%-69.1%2.026%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company21,131$0.96M0.0%+100.7%0.198%Search for SEC Filing on Google Icon
8/15/2024Millennium Management LLC241,649$10.94M0.0%-25.6%2.261%Search for SEC Filing on Google Icon
8/15/2024Darwin Global Management Ltd.325,140$14.27M1.7%N/A3.042%Search for SEC Filing on Google Icon
8/14/2024Integral Health Asset Management LLC100,000$4.53M0.4%N/A0.936%Search for SEC Filing on Google Icon
8/14/2024HighVista Strategies LLC38,793$1.76M0.6%N/A0.363%Search for SEC Filing on Google Icon
8/13/2024Ensign Peak Advisors Inc45,364$2.05M0.0%-32.8%0.424%Search for SEC Filing on Google Icon
8/7/2024ClariVest Asset Management LLC16,021$0.73M0.1%N/A0.150%Search for SEC Filing on Google Icon
8/6/2024Acadian Asset Management LLC15,854$0.72M0.0%N/A0.148%Search for SEC Filing on Google Icon
8/5/2024Victory Capital Management Inc.19,060$0.86M0.0%N/A0.178%Search for SEC Filing on Google Icon
8/3/2024TD Asset Management Inc40,800$1.85M0.0%+92.5%0.382%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers14,103$0.64M0.0%N/A0.132%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp30,236$1.37M0.0%N/A0.283%Search for SEC Filing on Google Icon
7/18/2024Assenagon Asset Management S.A.238,759$10.80M0.0%-8.0%2.233%Search for SEC Filing on Google Icon
5/17/2024Ikarian Capital LLC559,271$21.95M2.4%+185.5%5.232%Search for SEC Filing on Google Icon
5/16/2024Janus Henderson Group PLC339,074$13.36M0.0%N/A3.172%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD192,495$7.55M0.0%N/A1.801%Search for SEC Filing on Google Icon
5/15/2024Altitude Crest Partners Inc.103,703$4.07M1.7%N/A0.970%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.437,264$17.16M0.0%+143.7%4.162%Search for SEC Filing on Google Icon
5/1/2024Mirae Asset Global Investments Co. Ltd.24,880$0.98M0.0%N/A0.237%Search for SEC Filing on Google Icon
4/24/2024Assenagon Asset Management S.A.259,456$10.18M0.0%N/A2.469%Search for SEC Filing on Google Icon
5/15/2023Sio Capital Management LLC150,000$1.09M0.5%N/A3.559%Search for SEC Filing on Google Icon
5/10/2023Tekla Capital Management LLC5,143$37K0.0%-96.7%0.122%Search for SEC Filing on Google Icon
5/1/2023Virtu Financial LLC10,077$73K0.0%N/A0.239%Search for SEC Filing on Google Icon
1/25/2023Pinnacle Associates Ltd.731,350$84K0.0%-11.6%0.584%Search for SEC Filing on Google Icon
11/15/2022ETF Managers Group LLC4,710,319$0.78M0.0%-33.3%3.760%Search for SEC Filing on Google Icon
11/10/2022ExodusPoint Capital Management LP362,544$60K0.0%N/A0.289%Search for SEC Filing on Google Icon
11/1/2022Pinnacle Associates Ltd.827,240$0.14M0.0%-9.1%0.660%Search for SEC Filing on Google Icon
8/12/2022Ikarian Capital LLC862,527$0.22M0.0%-13.5%0.689%Search for SEC Filing on Google Icon
7/26/2022Mirae Asset Global Investments Co. Ltd.4,029,171$1.02M0.0%+7.3%3.217%Search for SEC Filing on Google Icon
6/2/2022Mirae Asset Global Investments Co. Ltd.3,754,954$2M0.0%-7.7%2.998%Search for SEC Filing on Google Icon
5/11/2022GSA Capital Partners LLP517,806$0.28M0.0%N/A0.413%Search for SEC Filing on Google Icon
5/10/2022Mirae Asset Global Investments Co. Ltd.3,754,954$2M0.0%-7.7%2.998%Search for SEC Filing on Google Icon
5/5/2022Pinnacle Associates Ltd.914,887$0.49M0.0%-3.4%0.731%Search for SEC Filing on Google Icon
4/28/2022Davy Global Fund Management Ltd435,285$0.23M0.0%+36.6%0.348%Search for SEC Filing on Google Icon
2/14/2022ETF Managers Group LLC14,138,998$8.53M0.2%+0.3%11.290%Search for SEC Filing on Google Icon
2/10/2022Acadian Asset Management LLC184,026$0.11M0.0%N/A0.147%Search for SEC Filing on Google Icon
2/8/2022Mirae Asset Global Investments Co. Ltd.4,070,006$2.51M0.0%+1.7%3.250%Search for SEC Filing on Google Icon
2/3/2022Cambridge Investment Research Advisors Inc.115,919$71K0.0%+27.5%0.093%Search for SEC Filing on Google Icon
2/2/2022Davy Global Fund Management Ltd318,668$0.20M0.0%+10.0%0.254%Search for SEC Filing on Google Icon
1/18/2022Aries Wealth Management107,800$66K0.0%+360.7%0.086%Search for SEC Filing on Google Icon
1/14/2022Spire Wealth Management45,000$28K0.0%N/A0.036%Search for SEC Filing on Google Icon
11/15/2021Penserra Capital Management LLC434,874$0.44M0.0%+19.2%0.347%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC1,386,108$1.41M0.0%+2.1%1.107%Search for SEC Filing on Google Icon
11/12/2021Vident Investment Advisory LLC147,113$0.15M0.0%N/A0.117%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.2,566,443$2.62M0.0%+8.7%2.049%Search for SEC Filing on Google Icon
10/27/2021Davy Global Fund Management Ltd289,627$0.30M0.0%-90.0%0.231%Search for SEC Filing on Google Icon
10/19/2021Pinnacle Associates Ltd.966,014$0.99M0.0%-3.2%0.771%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC85,031$0.16M0.0%-44.3%0.068%Search for SEC Filing on Google Icon
9/3/2021Parametric Portfolio Associates LLC61,837$0.11M0.0%+126.8%0.049%Search for SEC Filing on Google Icon
8/26/2021Y Intercept Hong Kong Ltd20,467$37K0.0%N/A0.016%Search for SEC Filing on Google Icon
8/17/2021Walleye Capital LLC168,824$0.31M0.0%N/A0.135%Search for SEC Filing on Google Icon
8/17/2021Walleye Trading LLC56,659$0.10M0.0%N/A0.045%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC1,242,977$2.28M0.0%N/A0.994%Search for SEC Filing on Google Icon
8/17/2021Price T Rowe Associates Inc. MD28,410$52K0.0%+148.3%0.023%Search for SEC Filing on Google Icon
8/17/2021Boothbay Fund Management LLC128,350$0.24M0.0%+15.7%0.103%Search for SEC Filing on Google Icon
8/16/2021LMR Partners LLP29,228$53K0.0%N/A0.023%Search for SEC Filing on Google Icon
8/16/2021Cubist Systematic Strategies LLC36,903$68K0.0%-62.9%0.030%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley2,592,114$4.74M0.0%-34.6%2.073%Search for SEC Filing on Google Icon
8/16/2021Credit Suisse AG59,269$0.11M0.0%+307.0%0.047%Search for SEC Filing on Google Icon
8/16/2021State Street Corp352,709$0.65M0.0%-77.2%0.282%Search for SEC Filing on Google Icon
8/16/2021Tibra Equities Europe Ltd145,500$0.27M0.1%N/A0.116%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.61,514$0.11M0.0%-71.4%0.049%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp213,327$0.39M0.0%-73.2%0.171%Search for SEC Filing on Google Icon
8/13/2021Jump Financial LLC23,466$43K0.0%N/A0.019%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC1,357,449$2.48M0.0%-15.6%1.086%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.5,462,050$10M0.0%+43.6%4.368%Search for SEC Filing on Google Icon
8/12/2021Penserra Capital Management LLC364,964$0.67M0.0%+204.2%0.292%Search for SEC Filing on Google Icon
8/12/2021Dimensional Fund Advisors LP65,794$0.12M0.0%N/A0.053%Search for SEC Filing on Google Icon
8/12/2021JPMorgan Chase & Co.187,252$0.34M0.0%-53.3%0.150%Search for SEC Filing on Google Icon
8/12/2021Bank of Montreal Can17,925$33K0.0%+763.0%0.014%Search for SEC Filing on Google Icon
8/12/2021Ergoteles LLC317,400$0.58M0.0%N/A0.254%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp197,232$0.36M0.0%-26.2%0.158%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.2,362,071$4.32M0.0%-58.4%1.889%Search for SEC Filing on Google Icon
8/11/2021Deutsche Bank AG54,008$98K0.0%-20.2%0.043%Search for SEC Filing on Google Icon
8/11/2021Susquehanna Fundamental Investments LLC53,033$97K0.0%-74.3%0.042%Search for SEC Filing on Google Icon
8/10/2021JTC Employer Solutions Trusteee Ltd33,185$61K0.0%N/A0.027%Search for SEC Filing on Google Icon
8/5/2021Platform Technology Partners60,000$0.11M0.0%N/A0.048%Search for SEC Filing on Google Icon
8/4/2021Graypoint LLC13,420$25K0.0%N/A0.011%Search for SEC Filing on Google Icon
8/4/2021Creative Planning238,024$0.44M0.0%-54.7%0.190%Search for SEC Filing on Google Icon
8/2/2021Pinnacle Associates Ltd.998,229$1.83M0.0%+1.5%0.798%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Corbus Pharmaceuticals logo
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells for the treatment of solid tumors; CRB-913, a peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts.
Read More on Corbus Pharmaceuticals

Today's Range

Now: $12.75
Low: $12.44
High: $13.34

50 Day Range

MA: $16.39
Low: $13.00
High: $19.15

52 Week Range

Now: $12.75
Low: $5.55
High: $61.90

Volume

252,587 shs

Average Volume

539,878 shs

Market Capitalization

$155.28 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.57

Who are the company insiders with the largest holdings of Corbus Pharmaceuticals?

Corbus Pharmaceuticals' top insider shareholders include:
  1. Cormorant Asset Management, Lp (Major Shareholder)
  2. Yuval Cohen (CEO)
  3. Sean F Moran (CFO)
Learn More about top insider investors at Corbus Pharmaceuticals.

Who are the major institutional investors of Corbus Pharmaceuticals?

Corbus Pharmaceuticals' top institutional investors include:
  1. State Street Corp — 4.89%
  2. Geode Capital Management LLC — 2.05%
  3. Ikarian Capital LLC — 0.00%
  4. Assenagon Asset Management S.A. — 2.07%
  5. Charles Schwab Investment Management Inc. — 0.78%
  6. HighVista Strategies LLC — 0.62%
Learn More about top institutional investors of Corbus Pharmaceuticals stock.

Which major investors are selling Corbus Pharmaceuticals stock?

In the last quarter, CRBP stock was sold by these institutional investors:
  1. Walleye Capital LLC
  2. Acuta Capital Partners LLC
  3. Assenagon Asset Management S.A.
Within the last year, company insiders that have sold Corbus Pharmaceuticals company stock include:
  1. Cormorant Asset Management, Lp (Major Shareholder)
  2. Yuval Cohen (CEO)
Learn More investors selling Corbus Pharmaceuticals stock.

Which major investors are buying Corbus Pharmaceuticals stock?

Within the last quarter, CRBP stock was acquired by institutional investors including:
  1. Ikarian Capital LLC
  2. State Street Corp
  3. Charles Schwab Investment Management Inc.
  4. HighVista Strategies LLC
  5. HealthInvest Partners AB
  6. Wexford Capital LP
  7. Wellington Management Group LLP
  8. abrdn plc
How Low-Cost Stocks Generate Monthly Income
From Darwin   |   Ad
Are you ready to transform your investment strategy and generate a steady monthly income? We’re excited to offer you our exclusive report, "Options Trading Strategy: 2 (Surprisingly) Low-Cost Stocks Primed for Generating Monthly Income," FREE!
👉 Yes, I Want the Free Report! 👈